A citation-based method for searching scientific literature

Wakana Oda, Yuki Fujita, Kousuke Baba, Hideki Mochizuki, Hitoshi Niwa, Toshihide Yamashita. Cell Death Dis 2021
Times Cited: 10







List of co-cited articles
103 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
Joanna A Korecka, Elizabeth B Moloney, Ruben Eggers, Barbara Hobo, Sanny Scheffer, Nienke Ras-Verloop, R Jeroen Pasterkamp, Dick F Swaab, August B Smit, Ronald E van Kesteren,[...]. J Neurosci 2017
17
70


Delayed administration of the human anti-RGMa monoclonal antibody elezanumab promotes functional recovery including spontaneous voiding after spinal cord injury in rats.
Andrea J Mothe, Marlon Coelho, Lili Huang, Philippe P Monnier, Yi-Fang Cui, Bernhard K Mueller, Peer B Jacobson, Charles H Tator. Neurobiol Dis 2020
17
60



RGMa inhibition with human monoclonal antibodies promotes regeneration, plasticity and repair, and attenuates neuropathic pain after spinal cord injury.
Andrea J Mothe, Nardos G Tassew, Alirezha P Shabanzadeh, Romeo Penheiro, Robin J Vigouroux, Lili Huang, Christine Grinnell, Yi-Fang Cui, Emma Fung, Philippe P Monnier,[...]. Sci Rep 2017
45
50

Uncoupling Neogenin association with lipid rafts promotes neuronal survival and functional recovery after stroke.
A P Shabanzadeh, N G Tassew, K Szydlowska, M Tymianski, P Banerjee, R J Vigouroux, J H Eubanks, L Huang, M Geraerts, P D Koeberle,[...]. Cell Death Dis 2015
27
50

RGMa mediates reactive astrogliosis and glial scar formation through TGFβ1/Smad2/3 signaling after stroke.
Rongrong Zhang, Yanping Wu, Fei Xie, Yiliang Zhong, Yu Wang, Mengxue Xu, Jinzhou Feng, Jason Charish, Philippe P Monnier, Xinyue Qin. Cell Death Differ 2018
54
50

RGMs: Structural Insights, Molecular Regulation, and Downstream Signaling.
Christian Siebold, Toshihide Yamashita, Philippe P Monnier, Bernhard K Mueller, R Jeroen Pasterkamp. Trends Cell Biol 2017
60
50

RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis.
Rieko Muramatsu, Takekazu Kubo, Masahiro Mori, Yuka Nakamura, Yuki Fujita, Tsugio Akutsu, Tatsusada Okuno, Junko Taniguchi, Atsushi Kumanogoh, Mari Yoshida,[...]. Nat Med 2011
83
50

Inhibiting repulsive guidance molecule-a suppresses secondary progression in mouse models of multiple sclerosis.
Shogo Tanabe, Yuki Fujita, Kaori Ikuma, Toshihide Yamashita. Cell Death Dis 2018
25
50

Repulsive guidance molecule-a and demyelination: implications for multiple sclerosis.
Takekazu Kubo, Shigeru Tokita, Toshihide Yamashita. J Neuroimmune Pharmacol 2012
12
40


Targeting repulsive guidance molecule A to promote regeneration and neuroprotection in multiple sclerosis.
Elena Demicheva, Yi-Fang Cui, Philip Bardwell, Stefan Barghorn, Martina Kron, Axel H Meyer, Martin Schmidt, Björn Gerlach, Mary Leddy, Eve Barlow,[...]. Cell Rep 2015
46
40

Sympathetic nervous system controls resolution of inflammation via regulation of repulsive guidance molecule A.
Andreas Körner, Martin Schlegel, Torsten Kaussen, Verena Gudernatsch, Georg Hansmann, Timo Schumacher, Martin Giera, Valbona Mirakaj. Nat Commun 2019
27
40

Diagnostic staging of Parkinson's disease: conceptual aspects.
H Przuntek, Th Müller, P Riederer. J Neural Transm (Vienna) 2004
106
30

Levodopa increases oxidative stress and repulsive guidance molecule A levels: a pilot study in patients with Parkinson's disease.
Thomas Müller, Isabel Trommer, Siegfried Muhlack, Bernhard K Mueller. J Neural Transm (Vienna) 2016
25
30


Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease.
Stephen Mullin, Morten Gersel Stokholm, Derralyn Hughes, Atul Mehta, Peter Parbo, Rainer Hinz, Nicola Pavese, David J Brooks, Anthony H V Schapira. Mov Disord 2021
28
30

Parkinson's disease and pesticides: A meta-analysis of disease connection and genetic alterations.
Hussien Ahmed, Abdelrahman Ibrahim Abushouk, Mohamed Gabr, Ahmed Negida, Mohamed M Abdel-Daim. Biomed Pharmacother 2017
54
30

Repulsive Guidance Molecule A Suppresses Adult Neurogenesis.
Toke Jost Isaksen, Yuki Fujita, Toshihide Yamashita. Stem Cell Reports 2020
8
37

Diagnosis and Treatment of Parkinson Disease: A Review.
Melissa J Armstrong, Michael S Okun. JAMA 2020
573
30

Multiplicity of α-Synuclein Aggregated Species and Their Possible Roles in Disease.
Pablo Gracia, José D Camino, Laura Volpicelli-Daley, Nunilo Cremades. Int J Mol Sci 2020
19
30


Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients.
Thomas Müller, Stefan Barghorn, Sven Lütge, Thomas Haas, Reinhold Mueller, Bjoern Gerlach, Gabi Öhm, Katrin Eilert, Isabel Trommer, Bernhard K Mueller. J Neural Transm (Vienna) 2015
11
30

Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer's disease.
Pravir Kumar, Niraj Kumar Jha, Saurabh Kumar Jha, Karunya Ramani, Rashmi K Ambasta. J Alzheimers Dis 2015
36
30

Lewy Bodies: A Spectator or Salient Killer?
Jeswinder Sian-Hulsmann, Camelia Monoranu, S Strobel, Peter Riederer. CNS Neurol Disord Drug Targets 2015
22
30

Parkinson's Disease: Biomarkers, Treatment, and Risk Factors.
Fatemeh N Emamzadeh, Andrei Surguchov. Front Neurosci 2018
175
30

Penetrance of Glucocerebrosidase (GBA) Mutations in Parkinson's Disease: A Kin Cohort Study.
Roberta Balestrino, Sara Tunesi, Silvana Tesei, Leonardo Lopiano, Anna L Zecchinelli, Stefano Goldwurm. Mov Disord 2020
30
30

Pesticide-induced gene mutations and Parkinson disease risk: a meta-analysis.
Xiaowei Liu, Tao Ma, Bo Qu, Yan Ji, Zhi Liu. Genet Test Mol Biomarkers 2013
15
30

There is no Parkinson disease.
William J Weiner. Arch Neurol 2008
47
30

GBA Variants in Parkinson's Disease: Clinical, Metabolomic, and Multimodal Neuroimaging Phenotypes.
Andrea Greuel, Jean-Pierre Trezzi, Enrico Glaab, Marina C Ruppert, Franziska Maier, Christian Jäger, Zdenka Hodak, Katja Lohmann, Yilong Ma, David Eidelberg,[...]. Mov Disord 2020
29
30

The SPID-GBA study: Sex distribution, Penetrance, Incidence, and Dementia in GBA-PD.
Letizia Straniero, Rosanna Asselta, Salvatore Bonvegna, Valeria Rimoldi, Giada Melistaccio, Giulia Soldà, Massimo Aureli, Matteo Della Porta, Ugo Lucca, Alessio Di Fonzo,[...]. Neurol Genet 2020
21
30

Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor.
Jodie L Babitt, Ying Zhang, Tarek A Samad, Yin Xia, Jie Tang, Jason A Campagna, Alan L Schneyer, Clifford J Woolf, Herbert Y Lin. J Biol Chem 2005
153
30

Secreted Chaperones in Neurodegeneration.
Kriti Chaplot, Timothy S Jarvela, Iris Lindberg. Front Aging Neurosci 2020
16
30

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
M Flint Beal, David Oakes, Ira Shoulson, Claire Henchcliffe, Wendy R Galpern, Richard Haas, Jorge L Juncos, John G Nutt, Tiffini Smith Voss, Bernard Ravina,[...]. JAMA Neurol 2014
203
30

Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's disease.
Avner Thaler, Shani Shenhar-Tsarfaty, Yanay Shaked, Tanya Gurevich, Nurit Omer, Anat Bar-Shira, Mali Gana-Weisz, Orly Goldstein, Meir Kestenbaum, Jesse M Cedarbaum,[...]. Sci Rep 2020
15
30

Modifying lipid rafts promotes regeneration and functional recovery.
Nardos G Tassew, Andrea J Mothe, Alireza P Shabanzadeh, Paromita Banerjee, Paulo D Koeberle, Rod Bremner, Charles H Tator, Philippe P Monnier. Cell Rep 2014
48
30

Central nervous system injury-induced repulsive guidance molecule expression in the adult human brain.
Jan M Schwab, Philippe P Monnier, Hermann J Schluesener, Sabine Conrad, Rudi Beschorner, Liang Chen, Richard Meyermann, Bernhard K Mueller. Arch Neurol 2005
69
30


Treating Parkinson's Disease with Antibodies: Previous Studies and Future Directions.
Anne-Marie Castonguay, Claude Gravel, Martin Lévesque. J Parkinsons Dis 2021
11
20

Clinical progression in Parkinson disease and the neurobiology of axons.
Hsiao-Chun Cheng, Christina M Ulane, Robert E Burke. Ann Neurol 2010
528
20

Neuroinflammation - a common thread in neurological disorders.
Nils Erik Gilhus, Günther Deuschl. Nat Rev Neurol 2019
62
20

Repulsive guidance molecules lock growth differentiation factor 5 in an inhibitory complex.
Tomas Malinauskas, Tina V Peer, Benjamin Bishop, Thomas D Mueller, Christian Siebold. Proc Natl Acad Sci U S A 2020
8
25

Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses.
Peter Riederer, Volker Ter Meulen. J Neural Transm (Vienna) 2020
15
20

Alzheimer's disease.
C A Lane, J Hardy, J M Schott. Eur J Neurol 2018
927
20

Stem Cell-Based Therapies for Parkinson Disease.
Zhaohui Liu, Hoi-Hung Cheung. Int J Mol Sci 2020
22
20

Human-induced pluripotent stem cells pave the road for a better understanding of motor neuron disease.
Beate Winner, Maria C Marchetto, Jürgen Winkler, Fred H Gage. Hum Mol Genet 2014
16
20

The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017.
Günther Deuschl, Ettore Beghi, Franz Fazekas, Timea Varga, Kalliopi A Christoforidi, Eveline Sipido, Claudio L Bassetti, Theo Vos, Valery L Feigin. Lancet Public Health 2020
129
20



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.